18F-labeled sigma-1 receptor modulator (University of Manchester/University of Sydney/Commissariat a l'Energie Atomique)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Name18F-labeled sigma-1 receptor modulator (University of Manchester/University of Sydney/Commissariat a l'Energie Atomique)
Drug Alias NameFluorine-18-IAM-6067IAM-6067-[18F]18F-IAM-6067
ClassificationDiagnostic agent (In vivo)
Mechanisms of ActionSigma opioid receptor modulatorsPositron-emission tomography enhancers
TargetsSigma opioid receptor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandUnited KingdomFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Manchester
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A